Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity Foundation.
Saved in:
| Title: | Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity Foundation. |
|---|---|
| Authors: | Sholl LM; From the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Sholl)., Awad M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (Awad)., Basu Roy U; Translational Science Research Program, LUNGevity Foundation, Chicago, Illinois (Basu Roy)., Beasley MB; the Department of Anatomic Pathology and Clinical Pathology, Mt. Sinai Medical Center, New York, New York (Beasley)., Cartun RW; the Department of Anatomic Pathology, Hartford Hospital, Hartford, Connecticut (Cartun)., Hwang DM; the Department of Laboratory Medicine & Pathobiology, Sunnybrook Health Science Centre, Toronto, Ontario, Canada (Hwang)., Kalemkerian G; the Department of Medical Oncology and Internal Medicine, University of Michigan Health, Ann Arbor (Kalemkerian)., Lopez-Rios F; Pathology Department, Hospital Universitario 12 de Octubre, Madrid, Spain (Lopez-Rios)., Mino-Kenudson M; the Department of Pathology, Massachusetts General Hospital, Boston (Mino-Kenudson)., Paintal A; the Department of Pathology, NorthShore University Health System, Evanston, Illinois (Paintal)., Reid K; Governance (Reid) and the Pathology and Laboratory Quality Center for Evidence-based Guidelines, College of American Pathologists, Northfield, Illinois(Ventura)., Ritterhouse L; the Department of Pathology, Foundation Medicine, Cambridge, Massachusetts (Ritterhouse)., Souter LA; Methodology Consultant, Hamilton, Ontario, Canada (Souter)., Swanson PE; the Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle (Swanson)., Ventura CB; Governance (Reid) and the Pathology and Laboratory Quality Center for Evidence-based Guidelines, College of American Pathologists, Northfield, Illinois(Ventura)., Furtado LV; the Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee (Furtado). |
| Source: | Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Jul 01; Vol. 148 (7), pp. 757-774. |
| Publication Type: | Journal Article; Practice Guideline |
| Journal Info: | Publisher: College of American Pathologists Country of Publication: United States NLM ID: 7607091 Publication Model: Print Cited Medium: Internet ISSN: 1543-2165 (Electronic) Linking ISSN: 00039985 NLM ISO Abbreviation: Arch Pathol Lab Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38625026 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity Foundation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sholl+LM%22">Sholl LM</searchLink>; From the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Sholl).<br /><searchLink fieldCode="AU" term="%22Awad+M%22">Awad M</searchLink>; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (Awad).<br /><searchLink fieldCode="AU" term="%22Basu+Roy+U%22">Basu Roy U</searchLink>; Translational Science Research Program, LUNGevity Foundation, Chicago, Illinois (Basu Roy).<br /><searchLink fieldCode="AU" term="%22Beasley+MB%22">Beasley MB</searchLink>; the Department of Anatomic Pathology and Clinical Pathology, Mt. Sinai Medical Center, New York, New York (Beasley).<br /><searchLink fieldCode="AU" term="%22Cartun+RW%22">Cartun RW</searchLink>; the Department of Anatomic Pathology, Hartford Hospital, Hartford, Connecticut (Cartun).<br /><searchLink fieldCode="AU" term="%22Hwang+DM%22">Hwang DM</searchLink>; the Department of Laboratory Medicine & Pathobiology, Sunnybrook Health Science Centre, Toronto, Ontario, Canada (Hwang).<br /><searchLink fieldCode="AU" term="%22Kalemkerian+G%22">Kalemkerian G</searchLink>; the Department of Medical Oncology and Internal Medicine, University of Michigan Health, Ann Arbor (Kalemkerian).<br /><searchLink fieldCode="AU" term="%22Lopez-Rios+F%22">Lopez-Rios F</searchLink>; Pathology Department, Hospital Universitario 12 de Octubre, Madrid, Spain (Lopez-Rios).<br /><searchLink fieldCode="AU" term="%22Mino-Kenudson+M%22">Mino-Kenudson M</searchLink>; the Department of Pathology, Massachusetts General Hospital, Boston (Mino-Kenudson).<br /><searchLink fieldCode="AU" term="%22Paintal+A%22">Paintal A</searchLink>; the Department of Pathology, NorthShore University Health System, Evanston, Illinois (Paintal).<br /><searchLink fieldCode="AU" term="%22Reid+K%22">Reid K</searchLink>; Governance (Reid) and the Pathology and Laboratory Quality Center for Evidence-based Guidelines, College of American Pathologists, Northfield, Illinois(Ventura).<br /><searchLink fieldCode="AU" term="%22Ritterhouse+L%22">Ritterhouse L</searchLink>; the Department of Pathology, Foundation Medicine, Cambridge, Massachusetts (Ritterhouse).<br /><searchLink fieldCode="AU" term="%22Souter+LA%22">Souter LA</searchLink>; Methodology Consultant, Hamilton, Ontario, Canada (Souter).<br /><searchLink fieldCode="AU" term="%22Swanson+PE%22">Swanson PE</searchLink>; the Department of Laboratory Medicine and Pathology, University of Washington Medical Center, Seattle (Swanson).<br /><searchLink fieldCode="AU" term="%22Ventura+CB%22">Ventura CB</searchLink>; Governance (Reid) and the Pathology and Laboratory Quality Center for Evidence-based Guidelines, College of American Pathologists, Northfield, Illinois(Ventura).<br /><searchLink fieldCode="AU" term="%22Furtado+LV%22">Furtado LV</searchLink>; the Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee (Furtado). – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227607091%22">Archives of pathology & laboratory medicine</searchLink> [Arch Pathol Lab Med] 2024 Jul 01; Vol. 148 (7), pp. 757-774. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Practice Guideline – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22College+of+American+Pathologists%22">College of American Pathologists </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7607091 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1543-2165 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200039985%22">00039985 </searchLink><i>NLM ISO Abbreviation: </i>Arch Pathol Lab Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38625026 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.5858/arpa.2023-0536-CP Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 757 Titles: – TitleFull: Programmed Death Ligand-1 and Tumor Mutation Burden Testing of Patients With Lung Cancer for Selection of Immune Checkpoint Inhibitor Therapies: Guideline From the College of American Pathologists, Association for Molecular Pathology, International Association for the Study of Lung Cancer, Pulmonary Pathology Society, and LUNGevity Foundation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sholl LM – PersonEntity: Name: NameFull: Awad M – PersonEntity: Name: NameFull: Basu Roy U – PersonEntity: Name: NameFull: Beasley MB – PersonEntity: Name: NameFull: Cartun RW – PersonEntity: Name: NameFull: Hwang DM – PersonEntity: Name: NameFull: Kalemkerian G – PersonEntity: Name: NameFull: Lopez-Rios F – PersonEntity: Name: NameFull: Mino-Kenudson M – PersonEntity: Name: NameFull: Paintal A – PersonEntity: Name: NameFull: Reid K – PersonEntity: Name: NameFull: Ritterhouse L – PersonEntity: Name: NameFull: Souter LA – PersonEntity: Name: NameFull: Swanson PE – PersonEntity: Name: NameFull: Ventura CB – PersonEntity: Name: NameFull: Furtado LV IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2024 Jul 01 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1543-2165 Numbering: – Type: volume Value: 148 – Type: issue Value: 7 Titles: – TitleFull: Archives of pathology & laboratory medicine Type: main |
| ResultId | 1 |
